Ellen Kapiteijn

16.7k citations

204 papers · 9.3k · 2 hit papers · h-index 37

Impact in

Oncology top 0.1%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Surgery top 0.2%
- Colorectal and Anal Carcinomas
- Anorectal Disease Treatments and Outcomes

Papers in

Oncology 141
- Cancer Immunotherapy and Biomarkers 64
- Cutaneous Melanoma Detection and Management 51
- CAR-T cell therapy research 51
- Colorectal Cancer Surgical Treatments 23
Molecular Biology 62
- Melanoma and MAPK Pathways 46

Co-authors: Cornelis J.�H. van de Velde (20 shared papers)Irıs D. Nagtegaal (8 shared papers)Hein Putter (4 shared papers)Corrie A.M. Marijnen (10 shared papers)J. Han van Krieken (3 shared papers)J.W.H. Leer (7 shared papers)Willem H. Steup (4 shared papers)Theo Wiggers (4 shared papers)
Journals: Annals of Oncology (23 papers)Journal of Clinical Oncology (22 papers)Cancers (18 papers)European Journal of Cancer (13 papers)European Journal of Endocrinology (6 papers)
Partner nations: Netherlands United States France

In The Last Decade

Ellen Kapiteijn

185 papers receiving 9.1k citations

Hit Papers

align trajectories log scale

Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control 2002 · 646 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Journal of Clinical Oncology
2001 New England Journal of Medicine

Peers

Countries citing papers authored by Ellen Kapiteijn

Since Specialization

Citations

This map shows the geographic impact of Ellen Kapiteijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Kapiteijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Kapiteijn more than expected).

Fields of papers citing papers by Ellen Kapiteijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Kapiteijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Kapiteijn. The network helps show where Ellen Kapiteijn may publish in the future.

Co-authors

The 25 scholars most cited alongside Ellen Kapiteijn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen Kapiteijn Line = papers co-authored together Ellen Kapiteijn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 204 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer New England Journal of Medicine ·Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, Hein Putter, Willem H. Steup, Theo Wiggers, H.J.T. Rutten, Lars Påhlman, Bengt Glimelius, J. Han van Krieken, J.W.H. Leer, Cornelis J.�H. van de Velde Hit paper breakdown →	2001	3053
2	Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control Journal of Clinical Oncology ·Irıs D. Nagtegaal, Cornelis J.�H. van de Velde, Erik van der Worp, Ellen Kapiteijn, Philip Quirke, J. Han van Krieken Hit paper breakdown →	2002	646
3	Acute Side Effects and Complications After Short-Term Preoperative Radiotherapy Combined With Total Mesorectal Excision in Primary Rectal Cancer: Report of a Multicenter Randomized Trial Journal of Clinical Oncology ·Corrie A.M. Marijnen, Ellen Kapiteijn, Cornelis J.�H. van de Velde, Hendrik Martijn, Willem H. Steup, Theo Wiggers, Elma Meershoek‐Klein Kranenbarg, J.W.H. Leer, (unknown)	2002	453
4	Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands British journal of surgery ·Ellen Kapiteijn, Hein Putter, Cornelis J.�H. van de Velde	2002	377
5	Neoantigen landscape dynamics during human melanoma–T cell interactions Nature ·Els M.E. Verdegaal, Noel F.C.C. de Miranda, Marten Visser, Tom J. Harryvan, Marit M. van Buuren, Rikke Andersen, Sine Reker Hadrup, Caroline E. van der Minne, Remko Schotte, Hergen Spits, John B.A.G. Haanen, Ellen Kapiteijn, Ton N. Schumacher, Sjoerd H. van der Burg	2016	339
6	Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 ⁺ T cell response Science Translational Medicine ·Pia Kvistborg, Daisy Philips, Sander Kelderman, Lois Hageman, Christian H. Ottensmeier, Deborah Joseph-Pietras, Marij J.P. Welters, Sjoerd van der Burg, Ellen Kapiteijn, Olivier Michielin, Emanuela Romano, Carsten Linnemann, Daniel E. Speiser, Christian U. Blank, John B.A.G. Haanen, Ton N. Schumacher	2014	288
7	Total Mesorectal Excision (TME) with or without Preoperative Radiotherapy in the Treatment of Primary Rectal Cancer: Prospective Randomised Trial with Standard Operative and Histopathological Techniques The European Journal of Surgery ·Ellen Kapiteijn	1999	214
8	Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial BMC Cancer ·Per J. Nilsson, Boudewijn van Etten, Geke A.P. Hospers, Lars Påhlman, Cornelis JH van de Velde, Geerard L. Beets, Lennart Blomqvist, Jannet C. Beukema, Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, Theo Wiggers, Bengt Glimelius	2013	201
9	Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma European Journal of Endocrinology ·Hendrieke C. Hoftijzer, Karen A. Heemstra, Hans Morreau, Marcel P. M. Stokkel, Eleonora P.M. Corssmit, Hans Gelderblom, Karin Weijers, Alberto M. Pereira, M. Huijberts, Ellen Kapiteijn, Johannes A. Romijn, Johannes W. A. Smit	2009	196
10	Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial International Journal of Radiation OncologyBiologyPhysics ·Corrie A.M. Marijnen, Irıs D. Nagtegaal, Ellen Kapiteijn, Elma Meershoek‐Klein Kranenbarg, E.M. Noordijk, J.H.J.M. van Krieken, Cornelis J.�H. van de Velde, J.W.H. Leer	2003	195
11	DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, Hein Putter, Willem H. Steup, Theo Wiggers, Harm Rutten, Lars Påhlman, Bengt Glimelius, J H Van Krieken, J.W.H. Leer, Cornelis JH van de Velde	2001	177
12	Mechanisms of oncogenesis in colon versus rectal cancer The Journal of Pathology ·Ellen Kapiteijn, Gerrit‐Jan Liefers, Louis Los, Elma Meershoek‐Klein Kranenbarg, J. Hermans, Robert A.E.M. Tollenaar, Yoshihiro Moriya, C.J.H. van de Velde, J.H.J.M. van Krieken	2001	155
13	Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands European Journal of Surgical Oncology ·Ellen Kapiteijn, Corrie A.M. Marijnen, A.C. Colenbrander, Elma Meershoek‐Klein Kranenbarg, Willem H. Steup, J.H.J.M. van Krieken, Hans C. van Houwelingen, J.W.H. Leer, Cornelis J.�H. van de Velde	1998	143
14	Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors Cancer Immunology Research ·Emma C. de Moel, Elisa A. Rozeman, Ellen Kapiteijn, Els M.E. Verdegaal, Annette Grummels, Jaap Bakker, T. Huizinga, John B.A.G. Haanen, René E. M. Toes, Diane van der Woude	2018	129
15	Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial European Journal of Endocrinology ·T Schneider, Randa M. Abdulrahman, Eleonora P.M. Corssmit, Hans Morreau, Johannes W. A. Smit, Ellen Kapiteijn	2012	112
16	Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination The Journal of Clinical Endocrinology & Metabolism ·Randa M. Abdulrahman, Herman Verloop, Hendrieke C. Hoftijzer, Erik Verburg, Guido C. Hovens, Eleonora P.M. Corssmit, Christoph Reiners, Hans Gelderblom, Alberto M. Pereira, Ellen Kapiteijn, Johannes A. Romijn, Theo J. Visser, Johannes W. A. Smit	2010	87
17	Everolimus in patients with advanced follicular-derived thyroid cancer; results of a phase II clinical trial. The Journal of Clinical Endocrinology & Metabolism ·T Schneider, Djoeke de Wit, Thera P. Links, Nielka P. van Erp, Jacobus J. M. van der Hoeven, Hans Gelderblom, C. F. M. Roozen, Monique M.E.M. Bos, Willem E. Corver, Tom van Wezel, Johannes W. A. Smit, Hans Morreau, Henk‐Jan Guchelaar, Ellen Kapiteijn	2016	76
18	New treatment modalities in advanced thyroid cancer Annals of Oncology ·Ellen Kapiteijn, T Schneider, Hans Morreau, Hans Gelderblom, J.W.R. Nortier, Johannes W. A. Smit	2011	72
19	Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer Drugs & Aging ·Yara van Holstein, Ellen Kapiteijn, Esther Bastiaannet, Frederiek van den Bos, Johanneke E.A. Portielje, Nienke A. de Glas	2019	70
20	Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types Cancers ·Monique K. van der Kooij, Frank M. Speetjens, Sjoerd H. van der Burg, Ellen Kapiteijn	2019	67

About Ellen Kapiteijn

Ellen Kapiteijn is a scholar working on Oncology, Molecular Biology, Immunology, Surgery and Ophthalmology, having authored 204 papers that have together received 9.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (64 papers), Cutaneous Melanoma Detection and Management (51 papers), CAR-T cell therapy research (51 papers), Melanoma and MAPK Pathways (46 papers), Immunotherapy and Immune Responses (34 papers), Ocular Oncology and Treatments (33 papers), Thyroid Cancer Diagnosis and Treatment (27 papers) and Colorectal Cancer Surgical Treatments (23 papers). The work is most often cited by research in Oncology (7.6k citations), Surgery (4.8k citations), Ophthalmology (506 citations), Immunology (1.2k citations) and Endocrinology, Diabetes and Metabolism (766 citations). Ellen Kapiteijn has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Cornelis J.�H. van de Velde, Irıs D. Nagtegaal, Hein Putter, Corrie A.M. Marijnen, J. Han van Krieken, J.W.H. Leer, Willem H. Steup, Theo Wiggers, Lars Påhlman and Bengt Glimelius. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancers, European Journal of Cancer and European Journal of Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ellen Kapiteijn

Impact in

Papers in i

In The Last Decade

Ellen Kapiteijn

Hit Papers

Peers

Countries citing papers authored by Ellen Kapiteijn

Fields of papers citing papers by Ellen Kapiteijn

All Works

About Ellen Kapiteijn

Explore authors with similar magnitude of impact

Papers in